Paolo Pinton Lab__Signal Transduction
Home – Lab members – Research – Lab facilities – Publications – Selected Publications — Lab funds – Map – Contacts & Information
CURRICULUM VITAE ETTORE SILVAGNI
Date and place of birth: Faenza (RA), 13th January 1987
Nationality: Italian
Affiliation and official address: Dept. of Medical Sciences, Rheumatology Unit, University of Ferrara and A.O.U. S. Anna, Cona (FE), via A. Moro, 8, 44124 Cona (FE)
Telephone: +39 0532 239653
e-mail: slvttr@unife.it
EDUCATION
2012: MD degree in Medicine and Surgery, summa cum laude (University of Ferrara)
2018: Graduation in Rheumatology, summa cum laude (University of Modena and Reggio Emilia)
2022: PhD in Molecular Medicine, summa cum laude (University of Ferrara)
CAREER/EMPLOYMENT
2018-present: Rheumatology Unit, Dept. of Medical Sciences (Sant'Anna Hospital, Ferrara)
2019: Research fellowship at Leiden University Medical Centre (LUMC), Rheumatology Unit, Leiden, N
2018-2022: PhD student in Molecular Medicine (University of Ferrara)
2022-2025: RTD-A Dept. of Medical Sciences (Sant'Anna Hospital, Ferrara)
2026-present: RTT Dept. of Medical Sciences (Sant'Anna Hospital, Ferrara)
AWARDS
2017: Awarded by the Italian Society for Rheumatology for the best English oral presentation at the 54° Annual Congress of the Italian Society for Rheumatology, hold in Rimini (RN), Italy.
2018: Awarded by the European League against Rheumatisms (EULAR) with the EULAR scientific training bursary, for the project “Changes in cerebral diffusivity parameters in Neuro-Psychiatric Systemic Lupus Erythematosus: longitudinal analysis of diffusion-tensor brain Magnetic Resonance Imaging”.
2018: Awarded by the Italian Society for Rheumatology for the best Poster Tour presentation at the 55° Annual Congress of the Italian Society for Rheumatology, hold in Rimini (RN), Italy.
2019: Awarded by the Italian Society for Rheumatology for the best English oral presentation at the 56° Annual Congress of the Italian Society for Rheumatology, hold in Rimini (RN), Italy.
2020: Awarded by Gruppo LES Italiano for participation at European Lupus Meeting.
2020: Awarded by Abbvie for Investigator Initiated Support (2020-2023) - “SELECTIVE JAK INHIBITION AT SYNOVIAL LEVEL: UNVEILING THE EFFECT OF UPADACITINIB IN REFRACTORY RHEUMATOID ARTHRITIS. A PILOT IN VITRO STUDY”.
2021: Awarded by Lilly for Investigator Initiated Support (2022-2027) - "Identification of synovial biomarkers of response to ixekizumab in refractory psoriatic arthritis: the PRECISE study"